David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.2B |
| 2 |
Boston Scientific
BSX
|
+$1.05B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$934M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$924M |
| 5 |
JPMorgan Chase
JPM
|
+$922M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.2B |
| 2 |
NVIDIA
NVDA
|
+$1.58B |
| 3 |
Palantir
PLTR
|
+$901M |
| 4 |
Netflix
NFLX
|
+$883M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$805M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.55% |
| 2 | Consumer Discretionary | 8.97% |
| 3 | Financials | 8.5% |
| 4 | Healthcare | 8.44% |
| 5 | Industrials | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRKRP
551
Bruker Corporation 6.375% Series A Preferred Stock
BRKRP
$1.17B
| $59M | 0.04% |
205,000
| – | – |
|
552
Arcutis Biotherapeutics
ARQT
$3.11B
| $58.8M | 0.04% |
2,496,222
-186,865
| -7% | -$4.77M |
|
|
CRWV
553
CALL
CoreWeave
CRWV
$47.6B
| $58.8M | 0.04% |
759,100
-25,900
| -3% | -$2.25M |
|
554
United Therapeutics
UTHR
$22B
| $58.8M | 0.04% |
99,106
-207,865
| -68% | -$104M |
|
555
BorgWarner
BWA
$13.1B
| $58.5M | 0.04% |
1,077,520
+946,029
| +719% | +$49.9M |
|
556
Vita Coco
COCO
$3.67B
| $58.2M | 0.04% |
1,214,433
-95,323
| -7% | -$5.2M |
|
557
Commault Systems
CVLT
$5.43B
| $58.1M | 0.03% |
745,556
+733,546
| +6,108% | +$69.6M |
|
558
Rogers Communications
RCI
$19.7B
| $58M | 0.03% |
1,508,717
+1,205,783
| +398% | +$45.9M |
|
559
Brookfield Renewable
BEPC
$6.1B
| $58M | 0.03% |
1,455,939
+792,033
| +119% | +$32.3M |
|
560
BJs Wholesale Club
BJ
$12.6B
| $57.5M | 0.03% |
584,251
-225,945
| -28% | -$21.8M |
|
561
CBRE Group
CBRE
$44B
| $57.5M | 0.03% |
424,129
+375,680
| +775% | +$57.1M |
|
562
Enbridge
ENB
$109B
| $57.3M | 0.03% |
1,057,890
+771,527
| +269% | +$39.3M |
|
563
Acuity Brands
AYI
$10.1B
| $57.3M | 0.03% |
204,399
+170,527
| +503% | +$51.8M |
|
564
ConocoPhillips
COP
$160B
| $57.3M | 0.03% |
433,817
-20,699
| -5% | -$2.29M |
|
565
Public Service Enterprise Group
PEG
$36.6B
| $57.2M | 0.03% |
706,045
-248,702
| -26% | -$20.4M |
|
566
FTI Consulting
FCN
$4.29B
| $57M | 0.03% |
322,665
-106,399
| -25% | -$18.2M |
|
567
PUT
CVS Health
CVS
$120B
| $56.9M | 0.03% |
792,400
-1,081,100
| -58% | -$83.3M |
|
568
Pembina Pipeline
PBA
$28.3B
| $56.8M | 0.03% |
1,270,043
+1,260,143
| +12,729% | +$53.4M |
|
569
CALL
Telus
TU
$15.5B
| $56.8M | 0.03% |
4,417,500
+1,492,500
| +51% | +$20.2M |
|
570
Zoom
ZM
$30.7B
| $56.7M | 0.03% |
705,685
+448,362
| +174% | +$37.6M |
|
571
Kosmos Energy
KOS
$1.7B
| $56.7M | 0.03% |
20,385,745
+14,420,042
| +242% | +$27.1M |
|
572
Mattel
MAT
$4.23B
| $56.4M | 0.03% |
3,883,399
+1,512,537
| +64% | +$27.6M |
|
573
Jazz Pharmaceuticals
JAZZ
$16.5B
| $56.4M | 0.03% |
298,090
+98,788
| +50% | +$17.3M |
|
574
Burlington
BURL
$20.8B
| $56.3M | 0.03% |
172,906
+118,450
| +218% | +$36.3M |
|
575
Zebra Technologies
ZBRA
$17.2B
| $56.3M | 0.03% |
269,069
-230,318
| -46% | -$54.1M |
|
Similar funds
David Shaw's Q1 2026 Portfolio in Review
As of Q1 2026, David Shaw held 5,226 positions worth $166B, down 8.8% from $182B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $15.1B in Q1 2026, closing 756 positions and reducing 1,922 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $805M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, David Shaw opened a new position in Venture Global Inc worth $211M.
- David Shaw's largest Q1 2026 buy was Venture Global Inc: 13,410,074 shares worth $211M.
- David Shaw added most to Broadcom in Q1 2026, an estimated $1.2B increase.
- David Shaw's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.2B.
- David Shaw fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $805M.
- David Shaw's ten largest holdings make up 11% of its $166B portfolio in Q1 2026.
- David Shaw opened 685 new positions and closed 756 in Q1 2026.
- David Shaw's portfolio value fell 8.8% quarter-over-quarter to $166B.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.